Aim: To prospectively determine the prevalence of germline CDKN2A mutations in the Slovenian cutaneous malignant melanoma (CMM) families. Methods: From January 2001 till the end of 2003 we prospectively screened 19 individuals from 11 CMM families, as well as 3 children with CMM aged from 6 to 13 years, with a negative family history. Results: Five distinct mutations were detected in 5 out of 11 screened families (10/19 individuals) and a previously recognized polymorphism was detected in a single family. Detected mutations were functionally deleterious (T281A, G68A, G301T, G71C and IVS – 1g > a). No mutations could be detected in 3 children. Conclusions: The prevalence of CDKN2A mutations among Slovenian CMM families was high, indicating t...
We report six of 16 U.K. melanoma families and two of 17 patients with multiple primary melanomas an...
Introduction: Multiple primary melanomas (MPM) occur up to 8% of patients with cutaneous malignant m...
Genetic susceptibility to primary cutaneous melanoma (PCM) may account for up to 12% of PCMs, presen...
Aim: To prospectively determine the prevalence of germline CDKN2A mutations in the Slovenian cutaneo...
Abstract Background Two high-risk genes have been implicated in the development of CM (cutaneous mel...
CDKN2A germline mutation frequency estimates are commonly based on families with several melanoma ca...
Cyclin-dependent kinase inhibitor 2A (CDKN2A or p16) is the major melanoma predisposition gene. In o...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
We have examined alterations in the cyclin-dependent kinase inhibitor 2A (CDKN2A), a major melanoma ...
BACKGROUND: : Inherited mutations in the CDKN2A tumor suppressor gene, which encodes the p16(INK4a) ...
Background: Cutaneous malignant melanoma (CMM) is an increasingly common cancer in fair-skinned peop...
Background: Inherited mutations in the CDKN2A tumor suppressor gene, which encodes the p16INK4a prot...
CDKN2A is the most common, most penetrant gene whom germline mutations predisposing to cutaneous fam...
Germline mutations within the coding region of CDKN2A have been observed in affected members of mela...
The genetic basis of melanoma susceptibility among Greek patients is uncharacterized. From 107 conse...
We report six of 16 U.K. melanoma families and two of 17 patients with multiple primary melanomas an...
Introduction: Multiple primary melanomas (MPM) occur up to 8% of patients with cutaneous malignant m...
Genetic susceptibility to primary cutaneous melanoma (PCM) may account for up to 12% of PCMs, presen...
Aim: To prospectively determine the prevalence of germline CDKN2A mutations in the Slovenian cutaneo...
Abstract Background Two high-risk genes have been implicated in the development of CM (cutaneous mel...
CDKN2A germline mutation frequency estimates are commonly based on families with several melanoma ca...
Cyclin-dependent kinase inhibitor 2A (CDKN2A or p16) is the major melanoma predisposition gene. In o...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
We have examined alterations in the cyclin-dependent kinase inhibitor 2A (CDKN2A), a major melanoma ...
BACKGROUND: : Inherited mutations in the CDKN2A tumor suppressor gene, which encodes the p16(INK4a) ...
Background: Cutaneous malignant melanoma (CMM) is an increasingly common cancer in fair-skinned peop...
Background: Inherited mutations in the CDKN2A tumor suppressor gene, which encodes the p16INK4a prot...
CDKN2A is the most common, most penetrant gene whom germline mutations predisposing to cutaneous fam...
Germline mutations within the coding region of CDKN2A have been observed in affected members of mela...
The genetic basis of melanoma susceptibility among Greek patients is uncharacterized. From 107 conse...
We report six of 16 U.K. melanoma families and two of 17 patients with multiple primary melanomas an...
Introduction: Multiple primary melanomas (MPM) occur up to 8% of patients with cutaneous malignant m...
Genetic susceptibility to primary cutaneous melanoma (PCM) may account for up to 12% of PCMs, presen...